Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) EBT Margin (2016 - 2025)

Historic EBT Margin for Traws Pharma (TRAW) over the last 14 years, with Q2 2025 value amounting to 45.7%.

  • Traws Pharma's EBT Margin rose 2163543000.0% to 45.7% in Q2 2025 from the same period last year, while for Sep 2025 it was 554.64%, marking a year-over-year increase of 620816500.0%. This contributed to the annual value of 62997.35% for FY2024, which is 540159300.0% down from last year.
  • Latest data reveals that Traws Pharma reported EBT Margin of 45.7% as of Q2 2025, which was up 2163543000.0% from 9128.07% recorded in Q1 2025.
  • Traws Pharma's EBT Margin's 5-year high stood at 45.7% during Q2 2025, with a 5-year trough of 216400.0% in Q2 2024.
  • Its 5-year average for EBT Margin is 19952.94%, with a median of 8538.6% in 2021.
  • Its EBT Margin has fluctuated over the past 5 years, first plummeted by 2000000000bps in 2024, then skyrocketed by 2000000000bps in 2025.
  • Quarter analysis of 5 years shows Traws Pharma's EBT Margin stood at 6719.64% in 2021, then plummeted by -52bps to 10239.29% in 2022, then rose by 22bps to 7967.86% in 2023, then decreased by -18bps to 9425.0% in 2024, then surged by 100bps to 45.7% in 2025.
  • Its EBT Margin was 45.7% in Q2 2025, compared to 9128.07% in Q1 2025 and 9425.0% in Q4 2024.